470 related articles for article (PubMed ID: 31854077)
21. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection.
Nixon IJ; Wang LY; Ganly I; Patel SG; Morris LG; Migliacci JC; Tuttle RM; Shah JP; Shaha AR
Br J Surg; 2016 Feb; 103(3):218-25. PubMed ID: 26511531
[TBL] [Abstract][Full Text] [Related]
22. Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis.
Back K; Choe JH; Kim JS; Kim JH
Eur J Surg Oncol; 2021 Jun; 47(6):1339-1345. PubMed ID: 33744024
[TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes of patients with papillary thyroid cancer who did not undergo prophylactic central neck dissection.
Huang H; Wu L; Liu W; Liu J; Liu Y; Xu Z
J Cancer Res Ther; 2020 Sep; 16(5):1077-1081. PubMed ID: 33004750
[TBL] [Abstract][Full Text] [Related]
25. A Retrospective Study of Lymph Node Yield in Lateral Neck Dissection for Papillary Thyroid Carcinoma.
Issa K; Stevens MN; Sun Y; Thomas S; Collins A; Cohen J; Esclamado RM; Rocke DJ
Ear Nose Throat J; 2022 Aug; 101(7):456-462. PubMed ID: 33090902
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
[TBL] [Abstract][Full Text] [Related]
27. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
[TBL] [Abstract][Full Text] [Related]
28. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis.
Chen S; Niu C; Peng Q; Tang K
Front Endocrinol (Lausanne); 2021; 12():556851. PubMed ID: 33796065
[TBL] [Abstract][Full Text] [Related]
29. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.
Lang BH; Wong KP; Wan KY; Lo CY
Ann Surg Oncol; 2012 Jan; 19(1):60-7. PubMed ID: 21681379
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.
Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R
Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706
[TBL] [Abstract][Full Text] [Related]
31. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
32. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
[TBL] [Abstract][Full Text] [Related]
33. Impact of lymph node metastases identified on central neck dissection (CND) on the recurrence of papillary thyroid cancer: potential role of BRAFV600E mutation in defining CND.
Alzahrani AS; Xing M
Endocr Relat Cancer; 2013 Feb; 20(1):13-22. PubMed ID: 23132792
[TBL] [Abstract][Full Text] [Related]
34. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.
Giordano D; Valcavi R; Thompson GB; Pedroni C; Renna L; Gradoni P; Barbieri V
Thyroid; 2012 Sep; 22(9):911-7. PubMed ID: 22827494
[TBL] [Abstract][Full Text] [Related]
35. Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients.
Taboni S; Paderno A; Giordano D; Albano D; Piana S; Zanetti E; Bertagna F; Grammatica A; Ghidini A; Cappelli C; Bozzola A; Baronchelli C; Nicolai P; Lombardi D
Laryngoscope; 2021 Mar; 131(3):E1029-E1034. PubMed ID: 33319385
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
[TBL] [Abstract][Full Text] [Related]
37. Factors affecting the adequacy of lymph node yield in prophylactic unilateral central neck dissection for papillary thyroid carcinoma.
Lang BH; Yih PC; Shek TW; Wan KY; Wong KP; Lo CY
J Surg Oncol; 2012 Dec; 106(8):966-71. PubMed ID: 22718439
[TBL] [Abstract][Full Text] [Related]
38. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer.
Kim WW; Park HY; Jung JH
Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Guo JN; Song LH; Yu PY; Yu SY; Deng SH; Mao XH; Xiu C; Sun J
J Surg Res; 2020 Sep; 253():69-78. PubMed ID: 32335393
[TBL] [Abstract][Full Text] [Related]
40. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
Ryu YJ; Cho JS; Park MH; Yoon JH
BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]